{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:07:03Z","timestamp":1790521623775,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["23720"],"award-info":[{"award-number":["23720"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN 2018-04773"],"award-info":[{"award-number":["RGPIN 2018-04773"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000001","name":"Alberta Cancer Foundation","doi-asserted-by":"publisher","award":["27246"],"award-info":[{"award-number":["27246"]}],"id":[{"id":"10.13039\/501100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.semcdb.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T17:22:38Z","timestamp":1603560158000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasis"],"prefix":"10.1016","volume":"114","author":[{"given":"\u00d6d\u00fcl","family":"Karayazi At\u0131c\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayantara","family":"Govindrajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isbel","family":"Lopetegui-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie S.","family":"Shemanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2007-0017","article-title":"What can we learn from rodents about prolactin in humans?","volume":"29","author":"Ben-Jonathan","year":"2008","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI0215912","article-title":"Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms","volume":"110","author":"Schuff","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.semcdb.2020.10.005_bb3","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1096\/fj.201701111RR","article-title":"Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo","volume":"32","author":"Bernard","year":"2018","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.semcdb.2020.10.005_bb4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2826.2008.01736.x","article-title":"Prolactin: a pleiotropic neuroendocrine hormone","volume":"20","author":"Grattan","year":"2008","journal-title":"J. Neuroendocr."},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/me.2013-1349","article-title":"Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions","volume":"28","author":"Marano","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0303-7207(95)03695-4","article-title":"Placental lactogen-I variant utilizes the prolactin receptor signaling pathway","volume":"116","author":"Cohick","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/me.2012-1297","article-title":"The role of prolactin receptor in GH signaling in breast cancer cells","volume":"27","author":"Xu","year":"2013","journal-title":"Mol. Endocrinol."},{"issue":"11","key":"10.1016\/j.semcdb.2020.10.005_bb8","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1172\/JCI119820","article-title":"Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice","volume":"100","author":"Wennbo","year":"1997","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb9","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1210\/en.2008-1057","article-title":"Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells","volume":"150","author":"Utama","year":"2009","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb10","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/JME-16-0150","article-title":"Prolactin receptor in breast cancer: marker for metastatic risk","volume":"57","author":"Shemanko","year":"2016","journal-title":"J. Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.semcdb.2020.10.005_bb11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1242\/dev.087643","article-title":"Mammary gland development: cell fate specification, stem cells and the microenvironment","volume":"142","author":"Inman","year":"2015","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.stemcr.2017.08.011","article-title":"Prolactin alters the mammary epithelial hierarchy, increasing progenitors and facilitating ovarian steroid action","volume":"9","author":"O\u2019Leary","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/joe.0.1710085","article-title":"Prolactin receptor expression in the epithelia and stroma of the rat mammary gland","volume":"171","author":"Camarillo","year":"2001","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/dvdy.1179","article-title":"Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland","volume":"222","author":"Hovey","year":"2001","journal-title":"Dev. Dyn."},{"issue":"1\/2","key":"10.1016\/j.semcdb.2020.10.005_bb15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1385\/ENDO:20:1-2:111","article-title":"Prolactin regulates mammary epithelial cell proliferation via autocrine\/paracrin mechanism","volume":"20","author":"Naylor","year":"2003","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2016.03.103","article-title":"Serotonin suppresses \u03b2-casein expression via PTP1B activation in human mammary epithelial cells","volume":"473","author":"Chiba","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3168\/jds.2015-9828","article-title":"Autocrine-paracrine regulation of the mammary gland","volume":"99","author":"Weaver","year":"2016","journal-title":"J. Dairy Sci."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/wdev.35","article-title":"Mammary gland development","volume":"1","author":"Macias","year":"2012","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/dbio.1999.9271","article-title":"Prolactin controls mammary gland development via direct and indirect mechanisms","volume":"210","author":"Brisken","year":"1999","journal-title":"Dev. Biol."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1026395229025","article-title":"Mammary gland development in prolactin receptor knockout mice","volume":"2","author":"Ormandy","year":"1997","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"10","key":"10.1016\/j.semcdb.2020.10.005_bb21","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1210\/endo.139.10.6243","article-title":"Null mutation of the prolactin receptor gene produces a defect in maternal behavior","volume":"139","author":"Lucas","year":"1998","journal-title":"Endocrinology"},{"issue":"23","key":"10.1016\/j.semcdb.2020.10.005_bb22","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","article-title":"Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene","volume":"16","author":"Horseman","year":"1997","journal-title":"EMBO J."},{"issue":"9\u201310","key":"10.1016\/j.semcdb.2020.10.005_bb23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1387\/ijdb.180109kx","article-title":"Prolactin stimulation affects the stem cell-dependent mammary repopulating ability of embryonic mammary anlagen","volume":"62","author":"Song","year":"2018","journal-title":"Int. J. Dev. Biol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","article-title":"Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation","volume":"9","author":"Asselin-Labat","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2011.01.004","article-title":"Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C\/EBP","volume":"335","author":"Goldhar","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1083\/jcb.200107065","article-title":"Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium","volume":"155","author":"Miyoshi","year":"2001","journal-title":"J. Cell Biol."},{"issue":"18","key":"10.1016\/j.semcdb.2020.10.005_bb27","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1128\/MCB.24.18.8037-8047.2004","article-title":"Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation","volume":"24","author":"Cui","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1101\/gad.11.2.179","article-title":"Stat5a is mandatory for adult mammary gland development and lactogenesis","volume":"11","author":"Liu","year":"1997","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.semcdb.2020.10.005_bb29","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1128\/MCB.24.12.5510-5520.2004","article-title":"Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice","volume":"24","author":"Wagner","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.semcdb.2020.10.005_bb30","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.2741\/2982","article-title":"Mammary epithelial stem and progenitor cells and the prolactin pathway","volume":"13","author":"Shemanko","year":"2008","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb31","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/nar\/gks1310","article-title":"Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A\/B concentration","volume":"41","author":"Yamaji","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.semcdb.2020.10.005_bb32","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.celrep.2016.11.079","article-title":"Lineage-specific and non-specific cytokine-sensing genes respond differentially to the master regulator STAT5","volume":"17","author":"Zeng","year":"2016","journal-title":"Cell Rep."},{"issue":"21","key":"10.1016\/j.semcdb.2020.10.005_bb33","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1242\/dev.00715","article-title":"Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5","volume":"130","author":"Long","year":"2003","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.semcdb.2020.10.005_bb34","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1091\/mbc.e06-02-0101","article-title":"The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells","volume":"17","author":"Muraoka-Cook","year":"2006","journal-title":"Mol. Biol. Cell"},{"issue":"48","key":"10.1016\/j.semcdb.2020.10.005_bb35","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1038\/sj.onc.1210501","article-title":"Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains","volume":"26","author":"Sundvall","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/dbio.2000.9961","article-title":"Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects","volume":"229","author":"Gallego","year":"2001","journal-title":"Dev. Biol."},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb37","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/me.2005-0473","article-title":"Socs2 and elf5 mediate prolactin-induced mammary gland development","volume":"20","author":"Harris","year":"2006","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ydbio.2009.02.032","article-title":"Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5","volume":"329","author":"Choi","year":"2009","journal-title":"Dev. Biol."},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb39","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/stem.1112","article-title":"Elf5 regulates mammary gland stem\/progenitor cell fate by influencing notch signaling","volume":"30","author":"Chakrabarti","year":"2012","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.semcdb.2020.10.005_bb40","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2002-0181","article-title":"A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice","volume":"17","author":"Binart","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"10.1016\/j.semcdb.2020.10.005_bb41","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1128\/MCB.00851-09","article-title":"Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1","volume":"30","author":"Creamer","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"39","key":"10.1016\/j.semcdb.2020.10.005_bb42","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1038\/onc.2010.274","article-title":"Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer","volume":"29","author":"Sakamoto","year":"2010","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.semcdb.2020.10.005_bb43","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1074\/jbc.M116.719377","article-title":"Zinc finger homeodomain factor Zfhx3 is essential for mammary lactogenic differentiation by maintaining prolactin signaling activity","volume":"291","author":"Zhao","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb44","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1210\/me.2004-0254","article-title":"Transcriptional changes underlying the secretory activation phase of mammary gland development","volume":"19","author":"Naylor","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ydbio.2009.01.019","article-title":"The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse","volume":"328","author":"Fernandez-Valdivia","year":"2009","journal-title":"Dev. Biol."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/stem.2271","article-title":"Rankl impairs lactogenic differentiation through inhibition of the prolactin\/Stat5 pathway at midgestation","volume":"34","author":"Cordero","year":"2016","journal-title":"Stem Cells"},{"issue":"42","key":"10.1016\/j.semcdb.2020.10.005_bb47","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.1073\/pnas.0708136104","article-title":"Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions","volume":"104","author":"Stull","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.semcdb.2020.10.005_bb48","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.bbamcr.2016.04.023","article-title":"Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with \u03b2-casein expression in mammary epithelial cells","volume":"1863","author":"Kobayashi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.semcdb.2020.10.005_bb49","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1074\/jbc.M115.685917","article-title":"A novel nectin-mediated cell adhesion apparatus that is implicated in prolactin receptor signaling for mammary gland development","volume":"291","author":"Kitayama","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.semcdb.2020.10.005_bb50","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1002\/jcp.25390","article-title":"The integrin-mediated ILK-Parvin-\u03b1Pix signaling axis controls differentiation in mammary epithelial cells","volume":"231","author":"Rooney","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb51","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41598-017-04783-6","article-title":"Extracellular matrix promotes clathrin-dependent endocytosis of prolactin and STAT5 activation in differentiating mammary epithelial cells","volume":"7","author":"Bridgewater","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb52","article-title":"Laminin-binding integrins are essential for the maintenance of functional mammary secretory epithelium in lactation","volume":"147","author":"Romagnoli","year":"2020","journal-title":"Development"},{"issue":"Pt 2","key":"10.1016\/j.semcdb.2020.10.005_bb53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1242\/jcs.00855","article-title":"A role for the cytoskeleton in prolactin-dependent mammary epithelial cell differentiation","volume":"117","author":"Zoubiane","year":"2004","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1083\/jcb.200503144","article-title":"Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation","volume":"171","author":"Naylor","year":"2005","journal-title":"J. Cell Biol."},{"issue":"16","key":"10.1016\/j.semcdb.2020.10.005_bb55","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1074\/jbc.273.16.9495","article-title":"Regulation of mammary differentiation by extracellular matrix involves protein-tyrosine phosphatases","volume":"273","author":"Edwards","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1083\/jcb.129.3.591","article-title":"Laminin mediates tissue-specific gene expression in mammary epithelia","volume":"129","author":"Streuli","year":"1995","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb57","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003285","article-title":"Leukocytes in mammary development and cancer","volume":"3","author":"Coussens","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.devcel.2015.07.015","article-title":"Adaptive immune regulation of mammary postnatal organogenesis","volume":"34","author":"Plaks","year":"2015","journal-title":"Dev. Cell"},{"issue":"11","key":"10.1016\/j.semcdb.2020.10.005_bb59","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1242\/dev.127.11.2269","article-title":"Postnatal mammary gland development requires macrophages and eosinophils","volume":"127","author":"Gouon-Evans","year":"2000","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/bcr441","article-title":"Requirement of macrophages and eosinophils and their cytokines\/chemokines for mammary gland development","volume":"4","author":"Gouon-Evans","year":"2002","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ydbio.2009.10.021","article-title":"Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis","volume":"337","author":"Lilla","year":"2010","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb62","first-page":"585","article-title":"Human colostral cells. I. Separation and characterization","volume":"38","author":"Crago","year":"1979","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10911-008-9067-7","article-title":"Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland","volume":"13","author":"Clapp","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10911-016-9369-0","article-title":"Role of prolactin in promotion of immune cell migration into the mammary gland","volume":"22","author":"Dill","year":"2017","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb65","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1210\/en.2016-1180","article-title":"Prolactin suppression of gonadotropin-releasing hormone initiation of mammary gland involution in female rats","volume":"157","author":"Rieanrakwong","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-0378(87)90031-3","article-title":"Uptake of lymphocytes fed to suckling rats. An autoradiographic study of the transit of labeled cells through the neonatal gastric mucosa","volume":"10","author":"Seelig","year":"1987","journal-title":"J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.semcdb.2020.10.005_bb67","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1096\/fj.201701154R","article-title":"Impaired prolactin actions mediate altered offspring metabolism induced by maternal high-fat feeding during lactation","volume":"32","author":"R\u00edos","year":"2018","journal-title":"FASEB J."},{"issue":"26","key":"10.1016\/j.semcdb.2020.10.005_bb68","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198012253032605","article-title":"Decreased bone density in hyperprolactinemic women","volume":"303","author":"Klibanski","year":"1980","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.semcdb.2020.10.005_bb69","first-page":"933","article-title":"Prevalence and magnitude of osteopenia in patients with prolactinoma","volume":"26","author":"Kayath","year":"1993","journal-title":"Braz. J. Med Biol. Res."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2265.2000.00902.x","article-title":"Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization","volume":"52","author":"Colao","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/bbrc.1996.1800","article-title":"Expression of prolactin receptors in human osteosarcoma cells","volume":"229","author":"Bataille-Simoneau","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/endo.140.1.6436","article-title":"Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice","volume":"140","author":"Cl\u00e9ment-Lacroix","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","article-title":"Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand\/osteoprotegerin ratio","volume":"42","author":"Seriwatanachai","year":"2008","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb74","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb75","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6656","key":"10.1016\/j.semcdb.2020.10.005_bb76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.semcdb.2020.10.005_bb79","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s12576-019-00714-4","article-title":"Morphological, hormonal, and molecular changes in different maternal tissues during lactation and post-lactation","volume":"69","author":"Canul-Medina","year":"2019","journal-title":"J. Physiol. Sci."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb80","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00134.2010","article-title":"Bone modeling in bromocriptine-treated pregnant and lactating rats: possible osteoregulatory role of prolactin in lactation","volume":"299","author":"Suntornsaratoon","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11102-020-01041-3","article-title":"Hyperprolactinemia and bone","volume":"23","author":"di Filippo","year":"2020","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb82","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1139\/Y08-037","article-title":"Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats","volume":"86","author":"Charoenphandhu","year":"2008","journal-title":"Can. J. Physiol. Pharmcol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13075-017-1290-4","article-title":"Prolactin blocks the expression of receptor activator of nuclear factor \u03baB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis","volume":"19","author":"Ledesma-Colunga","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb84","doi-asserted-by":"crossref","first-page":"djv338","DOI":"10.1093\/jnci\/djv338","article-title":"The role of prolactin in bone metastasis and breast cancer cell-mediated osteoclast differentiation","volume":"108","author":"Sutherland","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1026325630359","article-title":"Prolactin as an autocrine\/paracrine factor in breast tissue","volume":"2","author":"Clevenger","year":"1997","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"12","key":"10.1016\/j.semcdb.2020.10.005_bb86","first-page":"2591","article-title":"Prolactin synthesis and secretion by human breast cancer cells","volume":"55","author":"Ginsburg","year":"1995","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb87","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1023956223037","article-title":"Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth","volume":"79","author":"Liby","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"issue":"18","key":"10.1016\/j.semcdb.2020.10.005_bb88","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","article-title":"Plasma prolactin concentrations and risk of postmenopausal breast cancer","volume":"64","author":"Tworoger","year":"2004","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.semcdb.2020.10.005_bb89","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-13-0665","article-title":"A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development","volume":"73","author":"Tworoger","year":"2013","journal-title":"Cancer Res."},{"issue":"28","key":"10.1016\/j.semcdb.2020.10.005_bb90","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1200\/JCO.2014.56.1068","article-title":"Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer","volume":"32","author":"Tworoger","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.semcdb.2020.10.005_bb91","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1158\/1055-9965.EPI-14-0613","article-title":"Prolactin determinants in healthy women: a large cross-sectional study within the EPIC Cohort","volume":"23","author":"Tikk","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13058-015-0563-6","article-title":"Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study","volume":"17","author":"Tikk","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.semcdb.2020.10.005_bb93","doi-asserted-by":"crossref","first-page":"25998","DOI":"10.1038\/srep25998","article-title":"Plasma prolactin and breast cancer risk: a meta- analysis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb94","doi-asserted-by":"crossref","first-page":"pky055","DOI":"10.1093\/jncics\/pky055","article-title":"Inclusion of plasma prolactin levels in current risk prediction models of premenopausal and postmenopausal breast cancer","volume":"2","author":"Gabrielson","year":"2018","journal-title":"JNCI Cancer Spectr."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-006-9392-8","article-title":"MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research","volume":"104","author":"Rae","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcdb.2020.10.005_bb96","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/npjbcancer.2015.2","article-title":"Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014","volume":"1","author":"Prasad","year":"2015","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ijc.31067","article-title":"Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line","volume":"142","author":"Korch","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10549-013-2731-7","article-title":"Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer","volume":"142","author":"Nitze","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb99","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/PAI.0000000000000178","article-title":"Prolactin receptor expression is an independent favorable prognostic marker in human breast cancer","volume":"24","author":"Hachim","year":"2016","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10911-008-9073-9","article-title":"Transgenic models to study actions of prolactin in mammary neoplasia","volume":"13","author":"Arendt","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.semcdb.2020.10.005_bb101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-319-12114-7_9","article-title":"Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse","volume":"846","author":"O\u2019Leary","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb102","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/bcr2819","article-title":"Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer","volume":"13","author":"Arendt","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.semcdb.2020.10.005_bb103","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.celrep.2019.06.098","article-title":"A spontaneous aggressive ER\u03b1+ mammary tumor model is driven by Kras activation","volume":"28","author":"Campbell","year":"2019","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb104","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ijc.20484","article-title":"Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice","volume":"112","author":"Iavnilovitch","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/cdd.2013.116","article-title":"Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERalpha(+) tumorigenesis","volume":"21","author":"Chan","year":"2014","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb106","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ijc.11619","article-title":"Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers","volume":"108","author":"Cotarla","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.semcdb.2020.10.005_bb107","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1200\/JCO.2004.11.046","article-title":"Signal transducer and activator of transcription-5 activation and breast cancer prognosis","volume":"22","author":"Nevalainen","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.semcdb.2020.10.005_bb108","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1200\/JCO.2010.30.3552","article-title":"Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure","volume":"29","author":"Peck","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13058-018-0969-z","article-title":"Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions","volume":"20","author":"Johnston","year":"2018","journal-title":"Breast Cancer Res."},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/MCB.01220-13","article-title":"Stat5 regulates the phosphatidylinositol 3-kinase\/Akt1 pathway during mammary gland development and tumorigenesis","volume":"34","author":"Schmidt","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.semcdb.2020.10.005_bb111","doi-asserted-by":"crossref","first-page":"30934","DOI":"10.1038\/srep30934","article-title":"Prolactin pro-differentiation pathway in triple negative breast cancer: impact on prognosis and potential therapy","volume":"6","author":"L\u00f3pez-Ozuna","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb112","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/ijms20071640","article-title":"Concomitant expression of prolactin receptor and TGF\u03b2 receptors in breast cancer: association with less aggressive phenotype and favorable patient outcome","volume":"20","author":"Hachim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb113","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-013-0165-7","article-title":"Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland","volume":"5","author":"Faupel-Badger","year":"2014","journal-title":"Horm. Cancer"},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb114","first-page":"1321","article-title":"Prolactin and androgen R1881 induce pro-survival carboxypeptidase-D and EDD E3 ligase in triple-negative and HER2+ breast cancer","volume":"10","author":"MacDonald","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.18097\/pbmc20206601089","article-title":"[Analysis of prolactin receptor expression in breast cancer subtypes]","volume":"66","author":"Kalinina","year":"2020","journal-title":"Biomed. Khimiya"},{"issue":"10","key":"10.1016\/j.semcdb.2020.10.005_bb116","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/onc.2008.473","article-title":"Activation of the unliganded estrogen receptor by prolactin in breast cancer cells","volume":"28","author":"Gonz\u00e1lez","year":"2009","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb117","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbrc.2016.03.079","article-title":"PAK1 translocates into nucleus in response to prolactin but not to estrogen","volume":"473","author":"Oladimeji","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.semcdb.2020.10.005_bb118","doi-asserted-by":"crossref","first-page":"27353","DOI":"10.18632\/oncotarget.16040","article-title":"Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells","volume":"8","author":"Kavarthapu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb119","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajpath.2012.09.021","article-title":"The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer","volume":"182","author":"Fiorillo","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/js.2017-00399","article-title":"17beta-Estradiol and ICI182,780 differentially regulate STAT5 isoforms in female mammary epithelium, with distinct outcomes","volume":"2","author":"Jallow","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.semcdb.2020.10.005_bb121","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsbmb.2017.04.011","article-title":"Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models","volume":"176","author":"Leehy","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"17","key":"10.1016\/j.semcdb.2020.10.005_bb122","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/onc.2013.172","article-title":"Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression","volume":"33","author":"Sato","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2020.10.005_bb123","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110859","article-title":"Reciprocal fine-tuning of progesterone and prolactin-regulated gene expression in breast cancer cells","volume":"511","author":"Holloran","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb124","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12079-012-0168-0","article-title":"A pathway map of prolactin signaling","volume":"6","author":"Radhakrishnan","year":"2012","journal-title":"J. Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.gene.2016.06.044","article-title":"Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors","volume":"591","author":"Salazar","year":"2016","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb126","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jmb.2005.06.042","article-title":"Solution structure of human prolactin","volume":"351","author":"Teilum","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.semcdb.2020.10.005_bb127","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1191\/096120301717164949","article-title":"Prolactin receptor signal transduction","volume":"10","author":"Clevenger","year":"2001","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/me.2015-1319","article-title":"GHR\/PRLR heteromultimer is composed of GHR homodimers and PRLR homodimers","volume":"30","author":"Liu","year":"2016","journal-title":"Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.semcdb.2020.10.005_bb129","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/carcin\/bgp120","article-title":"Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase","volume":"30","author":"LaPensee","year":"2009","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb130","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2129","article-title":"Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity","volume":"10","author":"Howell","year":"2008","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb131","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/en.2017-00652","article-title":"ATM Is required for the prolactin-induced HSP90-mediated increase in cellular viability and clonogenic growth after DNA damage","volume":"159","author":"Karayazi Atici","year":"2018","journal-title":"Endocrinology"},{"issue":"18","key":"10.1016\/j.semcdb.2020.10.005_bb132","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1074\/jbc.M112.447631","article-title":"Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells","volume":"288","author":"Barcus","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13058-017-0801-1","article-title":"Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells","volume":"19","author":"Barcus","year":"2017","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb134","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/bcr3467","article-title":"Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment","volume":"15","author":"Yang","year":"2013","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.semcdb.2020.10.005_bb135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1158\/1541-7786.MCR-10-0130","article-title":"Prolactin receptor-integrin cross-talk mediated by SIRP\u03b1 in breast cancer cells","volume":"8","author":"Galbaugh","year":"2010","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb136","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1210\/me.2008-0341","article-title":"SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells","volume":"23","author":"Piazza","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb137","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/0008-5472.CAN-08-4033","article-title":"Impaired turnover of prolactin receptor contributes to transformation of human breast cells","volume":"69","author":"Plotnikov","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcdb.2020.10.005_bb138","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9378(72)90070-1","article-title":"L-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: a preliminary report","volume":"114","author":"Dickey","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.semcdb.2020.10.005_bb139","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJM197204132861518","article-title":"Levodopa relief of bone pain from breast cancer","volume":"286","author":"Dickey","year":"1972","journal-title":"N. Engl. J. Med."},{"issue":"7759","key":"10.1016\/j.semcdb.2020.10.005_bb140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(72)91249-4","article-title":"Prolactin, F.S.H., and L.H. in breast cancer: effect of levodopa and oophorectomy","volume":"1","author":"Minton","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.semcdb.2020.10.005_bb141","first-page":"929","article-title":"STAT5a\/b deficiency delays, but does not prevent, prolactin-driven prostate tumorigenesis in mice","volume":"11","author":"Boutillon","year":"2019"},{"issue":"4","key":"10.1016\/j.semcdb.2020.10.005_bb142","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000496833","article-title":"Low preoperative prolactin levels predict non-organ confined prostate cancer in clinically localized disease","volume":"103","author":"Porcaro","year":"2019","journal-title":"Urol. Int."},{"issue":"12","key":"10.1016\/j.semcdb.2020.10.005_bb143","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1073\/pnas.1819303116","article-title":"COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis","volume":"116","author":"Zheng","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2020.10.005_bb144","first-page":"44","article-title":"Human cytomegalovirus infection induces high expression of prolactin and prolactin receptors in ovarian cancer","volume":"9","author":"Rahbar","year":"2020"},{"key":"10.1016\/j.semcdb.2020.10.005_bb145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2018.07.003","article-title":"Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model","volume":"433","author":"Karthikeyan","year":"2018","journal-title":"Cancer Lett."},{"issue":"20","key":"10.1016\/j.semcdb.2020.10.005_bb146","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1158\/0008-5472.CAN-18-3064","article-title":"Prolactin promotes fibrosis and pancreatic cancer progression","volume":"79","author":"Tandon","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.semcdb.2020.10.005_bb147","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/en.2016-1903","article-title":"Autocrine prolactin stimulates endometrial carcinoma growth and metastasis and reduces sensitivity to chemotherapy","volume":"158","author":"Ding","year":"2017","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb148","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1158\/1535-7163.MCT-14-0819","article-title":"Inhibition of Stat5a\/b enhances proteasomal degradation of androgen receptor liganded by antiandrogens in prostate cancer","volume":"14","author":"Hoang","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.semcdb.2020.10.005_bb149","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.ajpath.2015.04.026","article-title":"Jak2-Stat5a\/b signaling induces epithelial-to-mesenchymal transition and stem-like cell properties in prostate cancer","volume":"185","author":"Talati","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.semcdb.2020.10.005_bb150","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1158\/1078-0432.CCR-17-2768","article-title":"STAT5A\/B blockade sensitizes prostate cancer to radiation through inhibition of RAD51 and DNA repair","volume":"24","author":"Maranto","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ror.0.0010001","article-title":"Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak\/Stat pathway","volume":"1","author":"Watson","year":"1996","journal-title":"Rev. Reprod."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb152","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcdb.2020.10.005_bb153","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2016.06.017","article-title":"JAK-STAT signaling in cancer: from cytokines to non-coding genome","volume":"87","author":"Pencik","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.semcdb.2020.10.005_bb154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2017.05.033","article-title":"Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition","volume":"451","author":"Groner","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"22","key":"10.1016\/j.semcdb.2020.10.005_bb155","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb156","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0304-4165(85)90162-X","article-title":"A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone","volume":"840","author":"Lau","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb157","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2015.06.010","article-title":"Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer","volume":"366","author":"Yonezawa","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcdb.2020.10.005_bb158","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijms17101764","article-title":"What is breast in the bone?","volume":"17","author":"Shemanko","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb159","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/er.2004-0016","article-title":"Development and potential clinical uses of human prolactin receptor antagonists","volume":"26","author":"Goffin","year":"2005","journal-title":"Endocr. Rev."},{"issue":"10","key":"10.1016\/j.semcdb.2020.10.005_bb160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ncpendmet0270","article-title":"Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?","volume":"2","author":"Goffin","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"38","key":"10.1016\/j.semcdb.2020.10.005_bb161","doi-asserted-by":"crossref","first-page":"35988","DOI":"10.1074\/jbc.M305687200","article-title":"Development of pure prolactin receptor antagonists","volume":"278","author":"Bernichtein","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.semcdb.2020.10.005_bb162","doi-asserted-by":"crossref","first-page":"13755","DOI":"10.1021\/bi049333p","article-title":"Mechanism for ordered receptor binding by human prolactin","volume":"43","author":"Sivaprasad","year":"2004","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.semcdb.2020.10.005_bb163","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1210\/endo.142.9.8369","article-title":"S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist","volume":"142","author":"Bernichtein","year":"2001","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb164","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/1535-7163.MCT-12-0886","article-title":"Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer","volume":"12","author":"Damiano","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.semcdb.2020.10.005_bb165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1634\/theoncologist.2015-0502","article-title":"Phase I study of the prolactin receptor antagonist LFA102 in metastatic breast and castration-resistant prostate cancer","volume":"21","author":"Agarwal","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.semcdb.2020.10.005_bb166","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-017-4370-x","article-title":"A pilot study of cabergoline for the treatment of metastatic breast cancer","volume":"165","author":"Costa","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.semcdb.2020.10.005_bb167","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/1535-7163.MCT-16-0839","article-title":"Preclinical activity of the novel anti-prolactin receptor (PRLR) antibody-drug conjugate REGN2878-DM1 in PRLR-positive breast cancers","volume":"16","author":"Kelly","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.semcdb.2020.10.005_bb168","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-020-01564-4","article-title":"A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer","volume":"39","author":"Zhou","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2020.10.005_bb169","doi-asserted-by":"crossref","DOI":"10.1007\/s10637-020-00960-z","article-title":"A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors","author":"Lemech","year":"2020","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.semcdb.2020.10.005_bb170","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.humpath.2016.02.010","article-title":"A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome","volume":"53","author":"Hachim","year":"2016","journal-title":"Human Pathology"}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952120301646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952120301646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:05:07Z","timestamp":1761066307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952120301646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":170,"alternative-id":["S1084952120301646"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2020.10.005","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}